With respect to iMFI values for LAP TGF-β1, lung adenocarcinoma patients showed an increase in the expression of LAP TGF-β1 that was 3.25-fold and 3.8-fold greater than the expression in the smoking and nonsmoking groups, respectively. This evidence concerns the gene TGFB1 and lung adenocarcinoma.